IN PHOTOS: What goes into making a Covid-19 vaccine
Sequencing of the genome, setting the stage for manufacture, conducting clinical trials, signing agreements, as well as holding protests. Forbes India takes a look at the Covid-19 vaccination journey in countries across the globe
Curated By: Amit Verma
_20200904072811_930x584.jpg "Commonwealth Scientific and Industrial Research Organisation (CSIRO)")
_20200904074217_930x584.jpg "French National Centre for Scientific Research (CNIR)")
August
A volunteer receives a Russian-made polyvalent vector vaccine for Covid-19 as part of clinical trials at Sechenov First Moscow State Medical University. Human trials for the vaccine, developed at Gamaleya Research Institute of Epidemiology and Microbiology, started in June. In August, the vaccine candidate became the first to receive regulatory approval, despite skepticism. It is expected to be available to the general public from January 2021
